Showing results (21-30 of 369) with videos related to
Sort By:
Pageof 37
Expert Review of Anticancer Therapy|October 6, 2006
Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugsRobin L Jones, Michael S EwerExpert Opinion on Drug Safety|July 23, 2004
Efficacy and safety of trastuzumabRobin L Jones, Ian E SmithMedical Oncology (Northwood, London, England)|August 22, 2018
Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcomaAlexandra Pender, Elizabeth J Davis, Dharmisha Chauhan, et al.Expert Opinion on Drug Safety|May 6, 2021
Managing the risk of toxicity in the treatment of elderly patients with soft tissue sarcomasSamia Arifi, Anastasia Constantinidou, Robin L JonesFrontiers in Oncology|April 8, 2020
The Emerging Role of Platelets in the Formation of the Micrometastatic Niche: Current Evidence and Future PerspectivesStavros Gkolfinopoulos, Robin L Jones, Anastasia ConstantinidouFuture Oncology (London, England)|November 4, 2021
Dedifferentiated chondrosarcoma: current standards of careAbhay K Kattepur, Robin L Jones, Aashish GuliaOncotargets and Therapy|March 26, 2013
Targeted treatment for advanced soft tissue sarcoma: profile of pazopanibRajeev Rajendra, Robin L Jones, Seth M PollackFuture Oncology (London, England)|February 19, 2013
Management of gastrointestinal stromal tumorsRajeev Rajendra, Seth M Pollack, Robin L JonesExpert Opinion on Pharmacotherapy|August 11, 2015
Current and advancing systemic treatment options for soft tissue sarcomasSamuel J Harris, Charlotte Benson, Robin L JonesExpert Review of Clinical Pharmacology|February 14, 2016
Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic optionsFlorence Duffaud, Robert G Maki, Robin L JonesPageof 37